Epsilon Theory: Adaptive Investing ... What's Your Market DNA?

Today's note, "Adaptive Investing: What's Your Market DNA?", begins 2014 with a new series of notes that I hope will stitch together many of the various Epsilon Theory threads I've been writing about over the past six months. It's a lengthy note (even for me) as there's a lot of introductory ground that has to be covered, but here's the basic premise: the human animal is hard-wired to participate in markets not only as a self-interested individual but also, whether we realize it or not, as a group-sensitive member of a distinct tribe speaking a distinct language with a distinct grammar. This perspective is totally alien to modern economic theory, and it opens up both the concepts and the toolboxes of evolutionary biology and linguistics, which is where I think you find the best game theory and information theory research of the past 20 years. I believe that much of what we find puzzling about markets today can be explained by seeing markets through this lens, and the potential is there to develop a useful new way of understanding risk and reward in portfolio construction ... Adaptive Investing.

Please feel free to forward the attached note to whomever you think might be interested, and all prior notes are available on the Epsilon Theory website. If you're receiving this note via forwarded email and you're not yet on the direct distribution list (and you find it a worthwhile read), I'd appreciate the opportunity to add you to the list. I'll be building the Adaptive Investing framework in plain sight and in real time through these notes, so I'd welcome the widest possible participation, as well as your thoughts and comments. As always, if you're no longer interested in receiving these notes, please reply to this email to that effect.

All the best,


Read..Adaptive Investing


This commentary is being provided to you by individual personnel of Salient Partners, L.P. and affiliates (“Salient”) and is provided as general information only and should not be taken as investment advice. The opinions expressed in these materials represent the personal views of the author(s) and do not necessarily represent the opinions of Salient. It is not investment research or a research recommendation, as it does not constitute substantive research or analysis. Any action that you take as a result of information contained in this document is ultimately your responsibility. Salient will not accept liability for any loss or damage, including without limitation to any loss of profit, which may arise directly or indirectly from use of or reliance on such information. Consult your investment advisor before making any investment decisions.  It must be noted, that no one can accurately predict the future of the market with certainty or guarantee future investment performance. Past performance is not a guarantee of future results.

Statements in this communication are forward-looking statements of Salient.

The forward-looking statements and other views expressed herein are as of the date of this publication. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements, and there is no guarantee that any predictions will come to pass. The views expressed herein are subject to change at any time, due to numerous market and other factors. Salient disclaims any obligation to update publicly or revise any forward-looking statements or views expressed herein.

This information is neither an offer to sell nor a solicitation of any offer to buy any securities. Any offering or solicitation will be made only to eligible investors and pursuant to any applicable Private Placement Memorandum and other governing documents, all of which must be read in their entirety.

Salient commentary has been prepared without regard to the individual financial circumstances and objectives of persons who receive it. Salient recommends that investors independently evaluate particular investments and strategies, and encourage investors to seek the advice of a financial advisor. The appropriateness of a particular investment or strategy will depend on an investor’s individual circumstances and objectives.